Acylact, vaginal suppositories 10 pcs

Acylact has high antagonistic activity against pathogenic and opportunistic microbes, including staphylococci, enteropathogenic E. coli and proteins, which determines the corrective action of the drug in violation of the bacteriocenosis of the female genitalia.

Indications

nonspecific colpitis. Prescribed as an independent remedy or after completing a course of antibacterial therapy;
vaginal dysbiosis, including bacterial vaginosis. Prescribed as an independent remedy or in complex therapy;
subacute and chronic stages of inflammatory processes in the female genital area. Prescribed after completion of a course of antibacterial therapy for the purpose of rehabilitation;
hormonally dependent colpitis, senile, etc. Prescribed as an independent remedy or against the background of specific hormonal therapy;
preparation for planned gynecological operations in order to prevent postoperative infectious complications;
prenatal preparation of pregnant women at risk for the development of inflammatory diseases for the purpose of prevention and treatment of vaginal dysbiosis;
as an adjuvant in combination with and after specific antimicrobial, antiviral and immunomodulatory therapy in the treatment of urogenital infections and sexually transmitted diseases (gonorrhea, urogenital chlamydia, urogenital herpes, etc.);

The combined use of suppositories and one of the oral forms of acylact is recommended.

Pharmacological effect

Acylact has high antagonistic activity against pathogenic and opportunistic microbes, including staphylococci, enteropathogenic Escherichia coli, Proteus, which determines the corrective effect of the drug in disorders of bacteriocenosis of the female genitalia.

Special instructions

The use of Acelact suppositories can be combined with the simultaneous administration of antimicrobial, antiviral and immunomodulatory therapy.

However, it is not recommended to combine it with simultaneous local administration of antibacterial drugs.

Active ingredient

Lactobacillus acidophilus

Composition

1 sup. contains live individuals of acidophilic lactobacilli no less than 107.

suppository base:

hard fat;

paraffin;

emulsifier.

Contraindications

A contraindication to the use of Acylact in suppositories is candidiasis, since in some cases a rapid shift in pH to the acidic side promotes the growth of fungi.

Acylact in this case is used after specific antifungal therapy or after the use of Bifidumbacterin in suppositories.

Side Effects

Not identified.

Storage conditions

At 2–10 °C

Shelf life

1 year

Manufacturer

Lanafarm, Russia